Lundbeck Announces Change in Board Leadership
News related to:H. Lundbeck A/S · 1 min read
VALBY, Denmark, Oct. 18, 2026 /CourierPR/ -- H. Lundbeck A/S, a biopharmaceutical company focusing on brain health, announced significant changes to its board of directors. Dorothea Wenzel, who has served as the Chair of the Board since March 2025, will step down at the Annual General Meeting (AGM) in 2027. Following the AGM, the company plans to appoint Lars Fruergaard Jørgensen as the new Chair.
Effective November 10, 2026, Lars Fruergaard Jørgensen will join the board as an observer until the formal election at the AGM. Jørgensen, an accomplished pharmaceutical executive with over 30 years of international experience, previously served as President and Chief Executive Officer of Novo Nordisk from 2017 to 2025. During his tenure, he led Novo Nordisk through a period of significant growth and transformation, strengthening its global leadership in diabetes care and establishing a leading position in obesity treatment.
The proposed change in leadership comes as Lundbeck prepares to enter the next phase of its Focused Innovator strategy. Over the past three years, the company has undergone a significant transformation, strengthening its commercial performance, advancing its pipeline, and building a stronger foundation for the future. The upcoming Scale phase of the strategy will focus on translating these achievements into sustainable long-term growth.
Lene Skole, Vice Chair of the Board, expressed gratitude to Wenzel for her commitment and dedication over the past five years.
Lars Fruergaard Jørgensen, who will take on the role of Chair, expressed excitement about the opportunity to lead Lundbeck at such a pivotal moment.
The nominated candidates for the Board of Directors will be included in the notice convening the AGM 2027. With more than 5,000 employees in over 20 countries and products available in more than 80 countries, Lundbeck remains committed to improving the lives of people with neurological and psychiatric diseases. For additional information, visit the company's website at www.lundbeck.com.